Acne is the most common skin disorder that affects over 80% of adults.

While acne may traditionally be viewed as a teenage "rite of passage," results from a groundbreaking national survey released today show that acne is a problem that also commonly affects adults.

Senetek PLC announced positive study results from a clinical trial of Pyratine-6 in patients with acne rosacea.

Rhytec has received FDA clearance to market a new indication for treating acne scars.

How the most potent drug available for the treatment of acne, 13-cis retinoic acid, also known as isotretinoin, combats acne and its mechanisms.

A Miami facial plastic surgeon is giving hope to patients suffering from disfiguring acne scarring with new laser technology.

Chemical peels using either alpha-hydroxy acid or beta-hydroxy acid are both highly effective in treating mild to moderately severe facial acne.

Obagi Medical announced the results of four studies of the CLENZIderm M.D. Acne Therapeutic Systems' two proprietary 3-step acne treatments.

Researchers conducted a global multi-center study using Isolaz to treat patients suffering from various degrees of acne, ranging from mild and moderate inflammatory acne to severe nodular and cystic acne.